| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 2.61 | 0.01 (+0.38%) | 2.50 - 4.75 | 8.8 thousand (Below Avg) |
Market data as of 4:00PM 05/24/13. Quotes are delayed by at least 15 min.
| Open | 2.60 |
|---|---|
| Previous Close | 2.60 |
| Day's Range | 2.57 - 2.62 |
| Market Cap | 135.4M |
| Avg Volume (10 Day) | 22.2K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -0.61 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Neutral |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Neutral |
| Borrows within reasonable limits? | Neutral |
| Stock is undervalued? | Fail |
| Have investors caught on? | Neutral |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
IMRIS Announces US Patent for Microsurgical Robot Concept
PR Newswire - Wednesday 05/22/2013 2:00 PM ET
IMRIS reports first quarter 2013 financial results
PR Newswire - Thursday 05/02/2013 4:01 PM ET
IMRIS establishes SYMBIS™ Surgical System Advisory Board
PR Newswire - Wednesday 05/01/2013 1:34 PM ET
IMRIS to hold first quarter 2013 results conference call and 2013 annual meeting of shareholders
PR Newswire - Tuesday 04/30/2013 1:06 PM ET
| IMRS | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 28.78% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | -- | |
| LT Debt/Equity | -- | |
| Earnings Yield | -- | |
| Price/Sales | 2.38 |
| Company | Last | Change |
|---|---|---|
| BIOLASE Inc | 4.58 | -3.98% |
| Harvard Bioscience Inc | 5.13 | -0.58% |
| LeMaitre Vascular Inc | 6.21 | +0.65% |
| Mesa Laboratories Inc | 52.38 | -0.13% |
| Utah Medical Products Inc | 47.98 | -0.12% |
Data is delayed by at least 15 min.